Skip to main content

Table 2 Relationship between factors and lymphedema in ovarian and uterine cancer patients who underwent pelvic lymph node dissection (univariate analysis; N = 680)

From: Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma

Factor Category N No. cases of lymphedema Lymphedema incidence (%) p value*
Cancer type Ovarian 133 28 21.1  
  Cervical 252 75 29.8  
  Endometrial 295 82 27.8 0.175
Age < 53 years 342 93 27.2  
  ≥ 53 years 338 92 27.2 1.000
Retroperitoneal approach** Closing 457 131 28.7  
  Opening 79 24 30.4 0.789
Omentectomy - 569 160 28.1  
  + 111 25 22.5 0.245
Enterectomy - 670 181 27.0  
  + 10 4 40.0 0.473
Salpingo-oophorectomy - 160 45 28.3  
  Unilateral 87 25 28.7  
  Bilateral 433 115 26.6 0.873
Hysterectomy - 12 4 33.3  
  Total 206 53 25.7  
  Modified radical 196 51 26.0  
  Radical 266 77 29.0 0.767
Neo-adjuvant chemotherapy - 645 173 26.8  
  + 35 12 34.3 0.334
Adjuvant chemotherapy - 393 111 28.2  
  + 287 74 25.8 0.487
Post-operative radiation - 548 136 24.8  
  + 132 49 37.1 0.006
Para-aortic lymph node dissection - 516 133 25.8  
  + 164 52 31.7 0.158
Total   680 185 27.2  
  1. * Fisher's exact test
  2. ** Except for 144 patients for whom this information was unknown.